Jaime L. Masferrer
- Pharmacology top 0.01%
- Genetics top 0.2%
- Molecular Biology top 1%
- Biochemistry top 0.02%
- Organic Chemistry top 0.5%
- Co-authors
- Karen SeibertBen S. ZweifelAlane KokiPhilip NeedlemanK. LeahyPeter C. IsaksonScott D. HauserB. Mark Woerner
- Topics
- Inflammatory mediators and NSAID effects (78 papers)Estrogen and related hormone effects (45 papers)Eicosanoids and Hypertension Pharmacology (33 papers)
- Cited by
- PharmacologyBiochemistryGenetics
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesSpainChile
In The Last Decade
Jaime L. Masferrer
134 papers receiving 17.2k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Pharmacology 9.7k
- Genetics 4.3k
- Molecular Biology 4.1k
- Biochemistry 2.9k
- Organic Chemistry 2.5k
Countries citing papers authored by Jaime L. Masferrer
This map shows the geographic impact of Jaime L. Masferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime L. Masferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime L. Masferrer more than expected).
Fields of papers citing papers by Jaime L. Masferrer
This network shows the impact of papers produced by Jaime L. Masferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime L. Masferrer. The network helps show where Jaime L. Masferrer may publish in the future.
Co-authorship network of co-authors of Jaime L. Masferrer
This figure shows the co-authorship network connecting the top 25 collaborators of Jaime L. Masferrer. A scholar is included among the top collaborators of Jaime L. Masferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime L. Masferrer. Jaime L. Masferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 45 | |
| 3 | 16 | |
| 4 | 54 | |
| 5 | 36 | |
| 6 | 30 | |
| 7 | 28 | |
| 8 | 72 | |
| 9 | 17 | |
| 10 | Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. | 177 |
| 11 | Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. | 125 |
| 12 | Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. | 60 |
| 13 | 35 | |
| 14 | Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor. | 232 |
| 15 | 32 | |
| 16 | 118 | |
| 17 | 32 | |
| 18 | 78 | |
| 19 | 359 | |
| 20 | Cytochrome P450 arachidonic acid metabolism in bovine corneal epithelium | 1 |
About Jaime L. Masferrer
Jaime L. Masferrer is a scholar working on Pharmacology, Biochemistry and Genetics, having authored 135 papers that have together received 17.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (78 papers), Estrogen and related hormone effects (45 papers) and Eicosanoids and Hypertension Pharmacology (33 papers). The work is most often cited by research in Pharmacology (9.7k citations), Biochemistry (2.9k citations) and Genetics (4.3k citations). Jaime L. Masferrer has collaborated with scholars based in United States, Spain and Chile. Frequent co-authors include Karen Seibert, Ben S. Zweifel, Alane Koki, Philip Needleman, K. Leahy, Peter C. Isakson, Scott D. Hauser, B. Mark Woerner, Mark G. Currie and Andrew J. Dannenberg. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.